BERLIN (Reuters) - Investor demand for shares in the medical vials division of Schott AG exceeds the deal size in its initial public offering, ...
BERLIN - Investor demand for shares in the medical vials division of Schott AG exceeds the deal size in its initial public offering, including the greenshoe option, banks told investors onBERLIN - Investor demand for
shares in the medical vials division of Schott AG exceeds the deal size in its initial public offering, including the greenshoe option, banks told investors on Tuesday, an hour after the start of the subscription period.
Philippines Latest News, Philippines Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Schott Pharma IPO's investor demand exceeds deal size -bookrunnersBERLIN (Reuters) - Investor demand for shares in the medical vials division of Schott AG exceeds the deal size in its initial public offering, ...
Read more »
Germany’s Schott Seeks €859 Million in IPO of Medical-Glass UnitSchott AG is looking to raise as much as €859 million ($917 million) from an initial public offering of its specialty medical-glassware division, in what is likely to be one of the biggest German stock listings this year.
Read more »
Klaviyo, Instacart raise IPO price rangesAfter Arm Holdings' (ARM) strong IPO debut, Klaviyo (KVYO) raised its IPO price range to between $27 and $29 per share. This comes after Instacart (CART) raised its own IPO price range as well, to between $28 and $30 per share. Yahoo Finance Live discusses what these debuts could mean for the IPO market.
Read more »
India's Torrent Pharma in talks with CVC, Bain Capital for Cipla bid- sourcesBy Aditya Kalra and M. Sriram DELHI/MUMBAI (Reuters) - India's Torrent Pharmaceuticals is in talks with private equity funds CVC Capital Partners and ...
Read more »
60 Degrees Pharma withdraws mid-stage study application for COVID drug(Reuters) - 60 Degrees Pharmaceuticals said on Monday it has withdrawn an application to the U.S. Food and Drug Administration (FDA) for a mid-stage ...
Read more »
60 Degrees Pharma withdraws mid-stage study application for COVID drug(Reuters) - 60 Degrees Pharmaceuticals said on Monday it has withdrawn an application to the U.S. Food and Drug Administration (FDA) for a mid-stage ...
Read more »